정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 23 | Completed | VIR-7831 for the Early Treatment of COVID-19 in Outpatients | Covid19 | Biological: VIR-7831 Drug: Placebo |
Phase 3 | Vir Biotechnology, Inc., GlaxoSmithKline | INDUSTRY | 1057 | All | 18 Years | Investigative Site, Anniston, Alabama, United States Investigative Site, Cullman, Alabama, United States Investigative Site, Mesa, Arizona, United States Investigative Site, Tucson, Arizona, United States Investigative Site, Los Angeles, California, United States Investigative Site, Los Angeles, California, United States Investigative Site, Northridge, California, United States Investigative Site, Oxnard, California, United States Investigative Site, Rolling Hills Estates, California, United States Investigative Site, Sacramento, California, United States Investigative Site, Doral, Florida, United States Investigative Site, Gainesville, Florida, United States Investigative Site, Hialeah, Florida, United States Investigative Site, Miami, Florida, United States Investigative Site, Miami, Florida, United States Investigative Site, Miami, Florida, United States Investigative Site, Miami, Florida, United States Investigative Site, Miami, Florida, United States Investigative Site, Miramar, Florida, United States Investigative Site, North Miami, Florida, United States Investigative Site, Palmetto Bay, Florida, United States Investigative Site, Pembroke Pines, Florida, United States Investigative Site, Pompano Beach, Florida, United States Investigative Site, Tampa, Florida, United States Investigative Site, Tampa, Florida, United States Investigative Site, Atlanta, Georgia, United States Investigative Site, Atlanta, Georgia, United States Investigative Site, Decatur, Georgia, United States Investigative Site, Stockbridge, Georgia, United States Investigative Site, Idaho Falls, Idaho, United States Investigative Site, Mishawaka, Indiana, United States Investigative Site, Lake Charles, Louisiana, United States Investigative Site, Marrero, Louisiana, United States Investigative Site, Baltimore, Maryland, United States Investigative Site, Caro, Michigan, United States Investigative Site, Hazelwood, Missouri, United States Investigative Site, Las Vegas, Nevada, United States Investigative Site, Las Vegas, Nevada, United States Investigative Site, Santa Fe, New Mexico, United States Investigative Site, Bronx, New York, United States Investigative Site, Asheboro, North Carolina, United States Investigative Site, Charlotte, North Carolina, United States Investigative Site, Columbus, Ohio, United States Investigative Site, Smithfield, Pennsylvania, United States Investigative Site, Chattanooga, Tennessee, United States Investigative Site, Austin, Texas, United States Investigative Site, Baytown, Texas, United States Investigative Site, Beaumont, Texas, United States Investigative Site, Denton, Texas, United States Investigative Site, El Paso, Texas, United States Investigative Site, Forney, Texas, United States Investigative Site, Houston, Texas, United States Investigative Site, Houston, Texas, United States Investigative Site, Houston, Texas, United States Investigative Site, Houston, Texas, United States Investigative Site, Humble, Texas, United States Investigative Site, Laredo, Texas, United States Investigative Site, McAllen, Texas, United States Investigative Site, Mesquite, Texas, United States Investigative Site, Sugar Land, Texas, United States Investigative Site, Kirkland, Washington, United States Investigative Site, Seattle, Washington, United States Investigative Site, Vienna, Austria Investigative Site, Vienna, Austria Investigative Site, Belo Horizonte, Minas Gerais, Brazil Investigative Site, Maringa, Parana, Brazil Investigative Site, Natal, Rio Grande Do Norte, Brazil Investigative Site, Passo Fundo, Rio Grande Do Sul, Brazil Investigative Site, Porto Alegre, Rio Grande Do Sul, Brazil Investigative Site, Porto Alegre, Rio Grande Do Sul, Brazil Investigative Site, Chapeco, Santa Catarina, Brazil Investigative Site, Santo Andre, Sao Paulo, Brazil Investigative Site, Vila Assuncao, Sao Paulo, Brazil Investigative Site, Campinas, Sao Paulo, Brazil Investigative Site, Sarnia, Ontario, Canada Investigative Site, Toronto, Ontario, Canada Investigative Site, Quebec, Quebec, Canada Investigative Site, Bellavista, Callao, Peru Investigative Site, El Agustino, Lima, Peru Investigative Site, Huaral, Lima, Peru Investigative Site, San Isidro, Lima, Peru Investigative Site, Bella Vista, Peru Investigative Site, Lima, Peru Investigative Site, Terrassa, Barcelona, Spain Investigative Site, Albacete, Spain Investigative Site, Centelles, Spain Investigative Site, Girona, Spain Investigative Site, Granada, Spain Investigative Site, Granada, Spain Investigative Site, Vigo, Spain Investigative Site, Belfast, United Kingdom |
| 22 | Completed | Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients | Covid19 | Drug: ensovibep | Phase 2 | Molecular Partners AG | INDUSTRY | 12 | All | 18 Years ~ 70 Years | Centre for Human Drug Research, Leiden, Netherlands |
| 21 | Recruiting | Viral Specific T Cell Therapy for COVID-19 Related Pneumonia | Symptomatic COVID-19 Infection Laboratory-Confirmed | Biological: SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes | Early Phase 1 | M.D. Anderson Cancer Center | OTHER | 16 | All | 18 Years | M D Anderson Cancer Center, Houston, Texas, United States |
| 20 | Withdrawn | Viral Specific T-cells for Treatment of COVID-19 | Viral Infection | Biological: Viral Specific T-cells (VSTs) | Phase 2 | Children's Hospital Medical Center, Cincinnati, Hoxworth Blood Center | OTHER | 0 | All | Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States | |
| 19 | Recruiting | Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients | Coronavirus Infections | Drug: virgin coconut oil (VCO) Other: placebo |
Phase 2 | Gadjah Mada University | OTHER | 60 | All | 18 Years | Central Public Hospital Dr. Sardjito, Yogyakarta, Indonesia RSUD Wonosari, Yogyakarta, Indonesia RSUP Sleman, Yogyakarta, Indonesia Teaching Hospital of Universitas Gadjah Mada (UGM), Yogyakarta, Indonesia |
| 18 | Recruiting | Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients | Covid19 | Drug: Virgin Coconut Oil | Phase 2 | University of the Philippines, Philippine Coconut Authority, Philippine Council for Health Research & Development | OTHER | 74 | All | 18 Years | Philippine General Hospital, Manila, Metro Manila, Philippines |
| 17 | Recruiting | Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo | COVID19 | Drug: Povidone-Iodine 0.4% NI Drug: Povidone-Iodine 0.5% NI Drug: Povidone-Iodine 0.6% NI Drug: Povidone-Iodine 0.5% NS Drug: Povidone-Iodine 0.6% NS Other: Placebo comparator: DW-NI Other: Placebo comparator: DW-NS |
Phase 2 | Pi Research Consultancy Center, Bangladesh, Dhaka Medical College | OTHER | 200 | All | 15 Years ~ 90 Years | Dhaka Medical College, Dhaka, Bangladesh |
